Factors affecting the structure of lyotropic liquid crystals and the correlation between structure and drug diffusion
Lyotropic liquid crystals (LLCs) formed by the self-assembly of amphiphilic molecules in a solvent (usually water) have attracted increasingly greater attention in the last few decades, especially the lamellar phase (L α ), the reversed bicontinuous cubic phase (Q 2 ) and the reversed hexagonal phas...
Saved in:
| Published in: | RSC advances Vol. 8; no. 13; pp. 6978 - 6987 |
|---|---|
| Main Authors: | , |
| Format: | Journal Article |
| Language: | English |
| Published: |
England
Royal Society of Chemistry
01-01-2018
The Royal Society of Chemistry |
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Lyotropic liquid crystals (LLCs) formed by the self-assembly of amphiphilic molecules in a solvent (usually water) have attracted increasingly greater attention in the last few decades, especially the lamellar phase (L
α
), the reversed bicontinuous cubic phase (Q
2
) and the reversed hexagonal phase (H
2
). Such phases offer promising prospects for encapsulation of a wide range of target molecules with various sizes and polarities owing to the unique internal structures. Also, different structures of mesophases can give rise to different diffusion coefficients. The bicontinuous cubic phase and the hexagonal phase have been demonstrated to control and sustain the release of active molecules. Furthermore, the structures are susceptible to many factors such as water content, temperature, pH, the presence of additives
etc.
Many researchers have been studying these influencing factors in order to accurately fabricate the desired phase. In this paper, we give a review of the characteristics of different structures of liquid crystalline phases, the influencing factors on the phase transition of liquid crystals and the relationship between structures of LLC and drug diffusion. We hope our review will provide some insights into how to manipulate in a controlled manner the rate of incorporating and transferring molecules by altering the structure of lyotropic mesophases.
Factors such as amphiphilic molecules , water content, temperature, pressure, light and magnetic field on the structures of LLCs. |
|---|---|
| AbstractList | Lyotropic liquid crystals (LLCs) formed by the self-assembly of amphiphilic molecules in a solvent (usually water) have attracted increasingly greater attention in the last few decades, especially the lamellar phase (L
α
), the reversed bicontinuous cubic phase (Q
2
) and the reversed hexagonal phase (H
2
). Such phases offer promising prospects for encapsulation of a wide range of target molecules with various sizes and polarities owing to the unique internal structures. Also, different structures of mesophases can give rise to different diffusion coefficients. The bicontinuous cubic phase and the hexagonal phase have been demonstrated to control and sustain the release of active molecules. Furthermore, the structures are susceptible to many factors such as water content, temperature, pH, the presence of additives
etc.
Many researchers have been studying these influencing factors in order to accurately fabricate the desired phase. In this paper, we give a review of the characteristics of different structures of liquid crystalline phases, the influencing factors on the phase transition of liquid crystals and the relationship between structures of LLC and drug diffusion. We hope our review will provide some insights into how to manipulate in a controlled manner the rate of incorporating and transferring molecules by altering the structure of lyotropic mesophases. Lyotropic liquid crystals (LLCs) formed by the self-assembly of amphiphilic molecules in a solvent (usually water) have attracted increasingly greater attention in the last few decades, especially the lamellar phase (L α ), the reversed bicontinuous cubic phase (Q 2 ) and the reversed hexagonal phase (H 2 ). Such phases offer promising prospects for encapsulation of a wide range of target molecules with various sizes and polarities owing to the unique internal structures. Also, different structures of mesophases can give rise to different diffusion coefficients. The bicontinuous cubic phase and the hexagonal phase have been demonstrated to control and sustain the release of active molecules. Furthermore, the structures are susceptible to many factors such as water content, temperature, pH, the presence of additives etc. Many researchers have been studying these influencing factors in order to accurately fabricate the desired phase. In this paper, we give a review of the characteristics of different structures of liquid crystalline phases, the influencing factors on the phase transition of liquid crystals and the relationship between structures of LLC and drug diffusion. We hope our review will provide some insights into how to manipulate in a controlled manner the rate of incorporating and transferring molecules by altering the structure of lyotropic mesophases. Factors such as amphiphilic molecules , water content, temperature, pressure, light and magnetic field on the structures of LLCs. Lyotropic liquid crystals (LLCs) formed by the self-assembly of amphiphilic molecules in a solvent (usually water) have attracted increasingly greater attention in the last few decades, especially the lamellar phase (Lα), the reversed bicontinuous cubic phase (Q2) and the reversed hexagonal phase (H2). Such phases offer promising prospects for encapsulation of a wide range of target molecules with various sizes and polarities owing to the unique internal structures. Also, different structures of mesophases can give rise to different diffusion coefficients. The bicontinuous cubic phase and the hexagonal phase have been demonstrated to control and sustain the release of active molecules. Furthermore, the structures are susceptible to many factors such as water content, temperature, pH, the presence of additives etc. Many researchers have been studying these influencing factors in order to accurately fabricate the desired phase. In this paper, we give a review of the characteristics of different structures of liquid crystalline phases, the influencing factors on the phase transition of liquid crystals and the relationship between structures of LLC and drug diffusion. We hope our review will provide some insights into how to manipulate in a controlled manner the rate of incorporating and transferring molecules by altering the structure of lyotropic mesophases. Lyotropic liquid crystals (LLCs) formed by the self-assembly of amphiphilic molecules in a solvent (usually water) have attracted increasingly greater attention in the last few decades, especially the lamellar phase (L ), the reversed bicontinuous cubic phase (Q ) and the reversed hexagonal phase (H ). Such phases offer promising prospects for encapsulation of a wide range of target molecules with various sizes and polarities owing to the unique internal structures. Also, different structures of mesophases can give rise to different diffusion coefficients. The bicontinuous cubic phase and the hexagonal phase have been demonstrated to control and sustain the release of active molecules. Furthermore, the structures are susceptible to many factors such as water content, temperature, pH, the presence of additives Many researchers have been studying these influencing factors in order to accurately fabricate the desired phase. In this paper, we give a review of the characteristics of different structures of liquid crystalline phases, the influencing factors on the phase transition of liquid crystals and the relationship between structures of LLC and drug diffusion. We hope our review will provide some insights into how to manipulate in a controlled manner the rate of incorporating and transferring molecules by altering the structure of lyotropic mesophases. |
| Author | Huang, Yiming Gui, Shuangying |
| AuthorAffiliation | Ministry of Education Department of Pharmacy Anhui Academy of Chinese Medicine Anhui University of Chinese Medicine Institute of Pharmaceutics Key Laboratory of Xin'an Medicine |
| AuthorAffiliation_xml | – name: Ministry of Education – name: Institute of Pharmaceutics – name: Department of Pharmacy – name: Anhui University of Chinese Medicine – name: Anhui Academy of Chinese Medicine – name: Key Laboratory of Xin'an Medicine |
| Author_xml | – sequence: 1 givenname: Yiming surname: Huang fullname: Huang, Yiming – sequence: 2 givenname: Shuangying surname: Gui fullname: Gui, Shuangying |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35540315$$D View this record in MEDLINE/PubMed |
| BookMark | eNpdkt1rFDEUxYNUbK198V0J-CLCapKZZGZehLK0VSgIos8hc-dmmzKbbPOh7H_ftFvX1UBI4P7O4YSTl-TIB4-EvObsI2fN8Am6aLhgrF89IyeCtWohmBqODu7H5CylW1aXklwo_oIcN1K2rOHyhJRLAznERI21CNn5Fc03SFOOBXKJSIOl8zbkGDYO6OzuipsoxG3KZq4iPz3iEGLE2WQXPB0x_0b0BxYP1BTLik7O2pIq9Io8t1WPZ0_nKfl5efFj-WVx_e3q6_L8egGykXkBig11j5Pl0yShZwBigMa0qhddj4ijHYcWJfCR26blTBjVjELaKjG2Vc0p-bzz3ZRxjROgz9HMehPd2sStDsbpfyfe3ehV-KUH1vUtH6rB-yeDGO4KpqzXLgHOs_EYStJCKSHbruap6Lv_0NtQoq_P04Jx1vfdIPtKfdhREENKEe0-DGf6oVC97L6fPxZ6VeG3h_H36J_6KvBmB8QE--nfH9HcA3LIqo8 |
| CitedBy_id | crossref_primary_10_1039_D0CP06226J crossref_primary_10_2174_1570179417666200916092109 crossref_primary_10_1016_j_molliq_2022_118684 crossref_primary_10_1016_j_molliq_2021_117594 crossref_primary_10_1016_j_apsusc_2019_144710 crossref_primary_10_1016_j_msec_2018_12_037 crossref_primary_10_1016_j_jddst_2024_105808 crossref_primary_10_1016_j_colsurfa_2020_125349 crossref_primary_10_1021_acsapm_2c01095 crossref_primary_10_1016_j_molliq_2020_113381 crossref_primary_10_3390_pharmaceutics15020366 crossref_primary_10_3390_ijms232113207 crossref_primary_10_3390_lubricants7090072 crossref_primary_10_1016_j_molliq_2024_124738 crossref_primary_10_1016_j_cis_2022_102808 crossref_primary_10_1016_j_jlr_2022_100183 crossref_primary_10_1016_j_jcis_2023_06_010 crossref_primary_10_1007_s40005_024_00670_1 crossref_primary_10_3390_pharmaceutics11110588 crossref_primary_10_1039_D1TA02748D crossref_primary_10_1080_08982104_2023_2272643 crossref_primary_10_1080_10717544_2020_1736210 crossref_primary_10_1016_j_ijpharm_2023_123482 crossref_primary_10_1016_j_molliq_2020_113771 crossref_primary_10_1016_j_jddst_2023_104821 crossref_primary_10_3390_molecules27144359 crossref_primary_10_1016_j_molliq_2021_117450 crossref_primary_10_1007_s11483_024_09853_7 crossref_primary_10_1080_17425247_2020_1819979 crossref_primary_10_1016_j_molliq_2022_120742 crossref_primary_10_1021_acs_molpharmaceut_3c00333 crossref_primary_10_1016_j_jconrel_2022_06_062 crossref_primary_10_1039_D1SM01100F crossref_primary_10_1016_j_bbamem_2022_183954 crossref_primary_10_1016_j_colsurfa_2020_125487 crossref_primary_10_1021_acsami_4c01455 crossref_primary_10_3390_gels10030181 crossref_primary_10_2478_ijame_2019_0012 crossref_primary_10_3390_molecules29133173 crossref_primary_10_1016_j_chemphyslip_2024_105377 crossref_primary_10_3389_fcell_2021_618102 crossref_primary_10_1021_acs_chemrev_1c00011 crossref_primary_10_1021_jacs_2c08583 crossref_primary_10_1016_j_ejps_2021_105956 crossref_primary_10_1016_j_ijpharm_2023_122612 crossref_primary_10_1016_j_ijpharm_2023_123546 crossref_primary_10_1021_acs_langmuir_0c01487 crossref_primary_10_1016_j_ijpharm_2019_05_021 crossref_primary_10_1002_aocs_12663 crossref_primary_10_1016_j_colsurfa_2021_127709 crossref_primary_10_1002_jsde_12757 crossref_primary_10_1088_1361_648X_aaebe2 crossref_primary_10_1021_acs_langmuir_3c03588 crossref_primary_10_1016_j_ijpharm_2021_120353 crossref_primary_10_1016_j_molliq_2021_115310 crossref_primary_10_1016_j_jconrel_2019_12_046 crossref_primary_10_1016_j_jcis_2024_05_096 crossref_primary_10_1016_j_cis_2020_102279 crossref_primary_10_1021_acsami_3c05656 crossref_primary_10_1080_1040841X_2020_1803208 crossref_primary_10_1088_1361_6528_ac3f54 crossref_primary_10_3390_molecules27196295 crossref_primary_10_1039_D0SM01075H crossref_primary_10_1016_j_addr_2023_114901 crossref_primary_10_1016_j_colsurfa_2020_125788 crossref_primary_10_1063_5_0180420 crossref_primary_10_1016_j_jddst_2022_103541 crossref_primary_10_1111_tpj_15070 crossref_primary_10_1039_D3CP00485F crossref_primary_10_1016_j_molstruc_2021_131117 crossref_primary_10_1016_j_drudis_2019_05_004 crossref_primary_10_1016_j_ejpb_2024_114259 crossref_primary_10_1016_j_ijpharm_2023_122633 crossref_primary_10_1002_jsde_12297 crossref_primary_10_1016_j_ejps_2022_106253 crossref_primary_10_1039_C9TC04079J crossref_primary_10_1021_acs_jpcb_2c06119 crossref_primary_10_2174_1389201024666230519103330 crossref_primary_10_1016_j_xphs_2019_10_021 crossref_primary_10_1007_s11095_021_02996_z crossref_primary_10_1038_s41598_023_31329_w crossref_primary_10_1208_s12249_021_01951_w crossref_primary_10_3390_biochem2040016 crossref_primary_10_3390_polym14071302 crossref_primary_10_1016_j_ijpharm_2019_118944 crossref_primary_10_1016_j_nano_2023_102689 crossref_primary_10_1016_j_jddst_2024_105822 crossref_primary_10_1016_j_actbio_2021_11_008 crossref_primary_10_1039_C9CC05517G crossref_primary_10_1111_nph_16318 crossref_primary_10_1007_s40005_021_00525_z crossref_primary_10_1208_s12249_019_1439_3 crossref_primary_10_1016_j_jcis_2024_03_067 crossref_primary_10_1080_10717544_2022_2144546 crossref_primary_10_1021_acs_jpcb_2c08150 crossref_primary_10_1002_app_51612 crossref_primary_10_3390_pharmaceutics16030396 crossref_primary_10_1021_acs_jpclett_3c02180 crossref_primary_10_1080_03639045_2020_1742147 crossref_primary_10_1149_1945_7111_acedd1 crossref_primary_10_3389_fnano_2020_588915 crossref_primary_10_3389_fpls_2020_00455 crossref_primary_10_1007_s11095_021_03014_y |
| Cites_doi | 10.1098/rsta.2006.1844 10.1021/la701206a 10.1119/1.18901 10.1021/jz100226v 10.1007/s00125-001-0751-z 10.1016/S0006-3495(98)77574-5 10.1016/j.jconrel.2016.02.042 10.1021/la0013805 10.1016/S0142-9612(99)00126-X 10.1016/S0005-2736(96)00156-3 10.1016/j.colsurfb.2010.02.029 10.1002/smll.201300348 10.1039/C3RA42737D 10.1021/ja072725+ 10.1021/la302901q 10.1166/jnn.2006.402 10.1038/386129a0 10.1016/0304-4157(90)90002-T 10.1021/la901195t 10.1038/nmat1496 10.1021/la061303v 10.1021/la046964b 10.1063/1.4961224 10.1016/0927-7757(94)02743-9 10.1016/j.tifs.2005.12.012 10.1016/j.cocis.2008.01.006 10.1021/la303833s 10.2147/IJN.S111736 10.1021/bi00486a031 10.12659/MSM.894484 10.1021/acsnano.7b06838 10.1016/j.ejpb.2008.07.008 10.3109/03639045.2010.491830 10.1021/la304563r 10.1021/nl050678i 10.1016/j.ijpharm.2005.11.033 10.1021/la5038662 10.1016/S1359-0286(96)80047-7 10.1021/jp711421k 10.1021/la903100m 10.1021/la052109w 10.1016/j.ijpharm.2007.03.020 10.1039/b609510k 10.1016/j.colsurfb.2005.03.011 10.1016/j.ejps.2007.07.006 10.1016/j.jconrel.2008.04.020 10.1039/c2fo00005a 10.1016/j.jconrel.2009.01.009 10.1016/j.ejps.2010.09.012 10.1016/j.jconrel.2015.02.034 10.1016/S0928-0987(01)00095-1 10.1016/S0168-3659(96)01596-9 10.1021/la100644s 10.1021/jp403840m 10.1016/j.ijpharm.2010.03.016 10.1016/S1359-0294(00)00020-0 10.1016/j.jcis.2007.07.011 10.1208/s12249-014-0277-6 10.1211/jpp.62.07.0005 10.1016/j.jconrel.2011.03.033 10.1039/C1CS15148G 10.1002/adma.201101760 10.1021/ja00147a600 10.1016/j.bpj.2008.10.057 10.1021/la061706v 10.1021/la305052q 10.1016/j.jcis.2006.12.084 10.1016/j.ijpharm.2008.08.022 10.1016/j.ijpharm.2006.03.010 10.1021/la404307x 10.1016/j.jconrel.2005.05.015 10.1081/DDC-100108370 10.1016/S0006-3495(93)81347-X 10.1016/S0959-440X(97)80075-9 10.1016/S0006-3495(87)83202-2 10.1016/j.ijpharm.2014.11.072 10.1021/ar100120v 10.1016/j.ejpb.2007.01.001 10.1083/jcb.12.2.207 10.1016/j.ijpharm.2009.12.032 10.1016/j.colsurfb.2015.03.051 10.1063/1.2915092 10.1016/0005-2736(83)90007-X 10.1016/j.ijpharm.2016.06.138 10.1016/j.ijpharm.2013.03.016 10.1007/s11095-005-8176-x 10.1016/S0169-409X(01)00108-9 10.1016/0378-5173(92)90102-8 10.1021/la0350812 10.1016/j.ijpharm.2013.06.006 10.1016/j.ijpharm.2011.09.022 10.1103/PhysRevLett.99.187801 10.1021/la9023019 10.1016/j.colsurfb.2010.01.013 10.1021/acsami.5b06413 10.1021/la200591u 10.1021/la010650w 10.1021/jp0659655 10.1016/S1359-0294(00)00040-6 10.1021/la950326z 10.1002/jps.10095 10.1016/j.eurpolymj.2010.07.001 10.1016/j.cocis.2006.07.002 10.1073/pnas.1603965113 10.1039/b004916f 10.1517/17425247.2010.515584 10.1021/j100358a010 |
| ContentType | Journal Article |
| Copyright | This journal is © The Royal Society of Chemistry. Copyright Royal Society of Chemistry 2018 This journal is © The Royal Society of Chemistry 2018 The Royal Society of Chemistry |
| Copyright_xml | – notice: This journal is © The Royal Society of Chemistry. – notice: Copyright Royal Society of Chemistry 2018 – notice: This journal is © The Royal Society of Chemistry 2018 The Royal Society of Chemistry |
| DBID | NPM AAYXX CITATION 7SR 8BQ 8FD JG9 7X8 5PM |
| DOI | 10.1039/c7ra12008g |
| DatabaseName | PubMed CrossRef Engineered Materials Abstracts METADEX Technology Research Database Materials Research Database MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | PubMed CrossRef Materials Research Database Engineered Materials Abstracts Technology Research Database METADEX MEDLINE - Academic |
| DatabaseTitleList | CrossRef Materials Research Database PubMed |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Chemistry |
| EISSN | 2046-2069 |
| EndPage | 6987 |
| ExternalDocumentID | 10_1039_C7RA12008G 35540315 c7ra12008g |
| Genre | Journal Article Review |
| GrantInformation_xml | – fundername: ; grantid: 81274099 |
| GroupedDBID | -JG 0-7 AAEMU ABGFH AEFDR AFVBQ AGSTE AUDPV BSQNT C6K EE0 EF- H~N J3I R7C R7E R7G RCNCU RPMJG RRC RSCEA SLH SMJ 0R~ 53G AAFWJ AAHBH AAIWI AAJAE AARTK AAWGC AAXHV ABEMK ABPDG ABXOH ACGFS ADBBV ADMRA AENEX AESAV AFLYV AGEGJ AGRSR AHGCF AKBGW ALMA_UNASSIGNED_HOLDINGS ANUXI APEMP ASKNT BCNDV BLAPV EBS EJD GROUPED_DOAJ H13 HZ~ M~E NPM O9- OK1 PGMZT RPM RVUXY ZCN AAYXX ABASK AETIL ANBJS AUNWK CITATION ECGLT J3G J3H RAOCF ROYLF YAE 7SR 8BQ 8FD JG9 7X8 5PM AFPKN |
| ID | FETCH-LOGICAL-c535t-c609c60bdf1dd5c80cc29c3a468278eeebfb94e5c1b1f34102a63b25f0bdaf463 |
| IEDL.DBID | RPM |
| ISSN | 2046-2069 |
| IngestDate | Tue Sep 17 21:21:31 EDT 2024 Fri Oct 25 22:33:01 EDT 2024 Thu Oct 10 17:21:48 EDT 2024 Thu Nov 21 23:17:56 EST 2024 Wed Oct 16 00:40:58 EDT 2024 Mon Jan 28 17:10:43 EST 2019 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 13 |
| Language | English |
| License | This journal is © The Royal Society of Chemistry. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c535t-c609c60bdf1dd5c80cc29c3a468278eeebfb94e5c1b1f34102a63b25f0bdaf463 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
| ORCID | 0000-0002-1643-1636 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9078419/ |
| PMID | 35540315 |
| PQID | 2010887958 |
| PQPubID | 2047525 |
| PageCount | 1 |
| ParticipantIDs | proquest_journals_2010887958 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9078419 rsc_primary_c7ra12008g crossref_primary_10_1039_C7RA12008G pubmed_primary_35540315 proquest_miscellaneous_2662547682 |
| ProviderPackageCode | J3I R7E RRC R7G AEFDR RPMJG -JG AGSTE RCNCU AUDPV EF- SLH BSQNT EE0 SMJ RSCEA AFVBQ C6K H~N 0-7 ABGFH AAEMU R7C |
| PublicationCentury | 2000 |
| PublicationDate | 2018-01-01 |
| PublicationDateYYYYMMDD | 2018-01-01 |
| PublicationDate_xml | – month: 01 year: 2018 text: 2018-01-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: Cambridge |
| PublicationTitle | RSC advances |
| PublicationTitleAlternate | RSC Adv |
| PublicationYear | 2018 |
| Publisher | Royal Society of Chemistry The Royal Society of Chemistry |
| Publisher_xml | – name: Royal Society of Chemistry – name: The Royal Society of Chemistry |
| References | Luzzati (C7RA12008G-(cit8)/*[position()=1]) 1997; 7 Dong (C7RA12008G-(cit78)/*[position()=1]) 2006; 22 Negrini (C7RA12008G-(cit25)/*[position()=1]) 2011; 27 Kaasgaard (C7RA12008G-(cit3)/*[position()=1]) 2006; 8 Pershan (C7RA12008G-(cit12)/*[position()=1]) 1982; 35 Báez-Santos (C7RA12008G-(cit80)/*[position()=1]) 2016; 514 Bertelsen (C7RA12008G-(cit67)/*[position()=1]) 2013; 3 Schwarz (C7RA12008G-(cit53)/*[position()=1]) 2001; 17 Kwon (C7RA12008G-(cit24)/*[position()=1]) 2011; 37 Larsson (C7RA12008G-(cit17)/*[position()=1]) 2000; 5 Martiel (C7RA12008G-(cit65)/*[position()=1]) 2015; 204 Garti (C7RA12008G-(cit46)/*[position()=1]) 2012; 3 Milak (C7RA12008G-(cit76)/*[position()=1]) 2015; 478 Barauskas (C7RA12008G-(cit37)/*[position()=1]) 2003; 19 Boni (C7RA12008G-(cit70)/*[position()=1]) 1983; 731 Seddon (C7RA12008G-(cit100)/*[position()=1]) 2006; 364 Ahmed (C7RA12008G-(cit106)/*[position()=1]) 2008; 70 Esposito (C7RA12008G-(cit97)/*[position()=1]) 2005; 22 Yariv (C7RA12008G-(cit98)/*[position()=1]) 2010; 78 Yaghmur (C7RA12008G-(cit101)/*[position()=1]) 2010; 26 Seddon (C7RA12008G-(cit56)/*[position()=1]) 2000; 2 Martiel (C7RA12008G-(cit64)/*[position()=1]) 2014; 30 Chen (C7RA12008G-(cit89)/*[position()=1]) 2015; 16 Sjölund (C7RA12008G-(cit68)/*[position()=1]) 1987; 52 Bender (C7RA12008G-(cit92)/*[position()=1]) 2008; 129 Barauskas (C7RA12008G-(cit116)/*[position()=1]) 2005; 5 Libster (C7RA12008G-(cit7)/*[position()=1]) 2007; 308 Bitancherbakovsky (C7RA12008G-(cit83)/*[position()=1]) 2009; 25 Antognini (C7RA12008G-(cit107)/*[position()=1]) 2016; 145 Borné (C7RA12008G-(cit85)/*[position()=1]) 2001; 17 Martiel (C7RA12008G-(cit57)/*[position()=1]) 2013; 29 Holmberg (C7RA12008G-(cit15)/*[position()=1]) 2002; 10 Dash (C7RA12008G-(cit102)/*[position()=1]) 2010; 67 Boyd (C7RA12008G-(cit66)/*[position()=1]) 2007; 340 Fong (C7RA12008G-(cit19)/*[position()=1]) 2009; 135 Negrini (C7RA12008G-(cit87)/*[position()=1]) 2012; 28 Larsson (C7RA12008G-(cit47)/*[position()=1]) 2009; 14 Barauskas (C7RA12008G-(cit117)/*[position()=1]) 2010; 391 Fong (C7RA12008G-(cit30)/*[position()=1]) 2016; 228 Nguyen (C7RA12008G-(cit14)/*[position()=1]) 2011; 153 Costa (C7RA12008G-(cit103)/*[position()=1]) 2001; 13 Parmar (C7RA12008G-(cit112)/*[position()=1]) 2015; 129 Li (C7RA12008G-(cit63)/*[position()=1]) 2015; 21 Boyd (C7RA12008G-(cit95)/*[position()=1]) 2007; 340 Yaghmur (C7RA12008G-(cit29)/*[position()=1]) 2010; 1 Turner (C7RA12008G-(cit50)/*[position()=1]) 1992; 2 Helledi (C7RA12008G-(cit93)/*[position()=1]) 2001; 27 Boyd (C7RA12008G-(cit109)/*[position()=1]) 2006; 318 Seddon (C7RA12008G-(cit52)/*[position()=1]) 1990; 1031 Vallooran (C7RA12008G-(cit33)/*[position()=1]) 2011; 23 Briggs (C7RA12008G-(cit51)/*[position()=1]) 1996; 6 Sagalowicz (C7RA12008G-(cit81)/*[position()=1]) 2013; 29 Didehban (C7RA12008G-(cit75)/*[position()=1]) 2010; 46 Fong (C7RA12008G-(cit28)/*[position()=1]) 2012; 28 Costa (C7RA12008G-(cit104)/*[position()=1]) 1996; 46 Lopes (C7RA12008G-(cit96)/*[position()=1]) 2007; 32 Yaghmur (C7RA12008G-(cit88)/*[position()=1]) 2006; 22 Fong (C7RA12008G-(cit60)/*[position()=1]) 2012; 41 Speziale (C7RA12008G-(cit42)/*[position()=1]) 2016; 113 Tenchov (C7RA12008G-(cit72)/*[position()=1]) 1998; 75 Rizwan (C7RA12008G-(cit1)/*[position()=1]) 2010; 7 Shah (C7RA12008G-(cit38)/*[position()=1]) 2007; 67 Bitancherbakovsky (C7RA12008G-(cit82)/*[position()=1]) 2010; 26 Bode (C7RA12008G-(cit113)/*[position()=1]) 2013; 448 Tangso (C7RA12008G-(cit31)/*[position()=1]) 2013; 117 Yuli (C7RA12008G-(cit91)/*[position()=1]) 2008; 112 Zabara (C7RA12008G-(cit26)/*[position()=1]) 2013; 9 Han (C7RA12008G-(cit61)/*[position()=1]) 2010; 41 Nguyen (C7RA12008G-(cit110)/*[position()=1]) 2010; 62 Wadsten-Hindrichsen (C7RA12008G-(cit36)/*[position()=1]) 2007; 315 Tenchov (C7RA12008G-(cit71)/*[position()=1]) 1996; 1285 Hyde (C7RA12008G-(cit44)/*[position()=1]) 1996; 1 Chang (C7RA12008G-(cit23)/*[position()=1]) 1997; 46 Fong (C7RA12008G-(cit32)/*[position()=1]) 2012; 7 Fong (C7RA12008G-(cit27)/*[position()=1]) 2010; 26 Angelova (C7RA12008G-(cit115)/*[position()=1]) 2013; 454 Fong (C7RA12008G-(cit74)/*[position()=1]) 2007; 111 Kim (C7RA12008G-(cit79)/*[position()=1]) 2015; 7 Drummond (C7RA12008G-(cit9)/*[position()=1]) 1999; 4 Lee (C7RA12008G-(cit108)/*[position()=1]) 2009; 365 Johnsson (C7RA12008G-(cit111)/*[position()=1]) 2006; 6 Clogston (C7RA12008G-(cit2)/*[position()=1]) 2005; 107 Luzzati (C7RA12008G-(cit48)/*[position()=1]) 1962; 12 Mezzenga (C7RA12008G-(cit54)/*[position()=1]) 2005; 21 Mezzenga (C7RA12008G-(cit77)/*[position()=1]) 2005; 4 Speziale (C7RA12008G-(cit43)/*[position()=1]) 2017; 11 Chung (C7RA12008G-(cit20)/*[position()=1]) 2002; 45 Israelachvili (C7RA12008G-(cit59)/*[position()=1]) 1994; 91 Yaghmur (C7RA12008G-(cit84)/*[position()=1]) 2006; 22 Eriksson (C7RA12008G-(cit69)/*[position()=1]) 1993; 64 Sagalowicz (C7RA12008G-(cit10)/*[position()=1]) 2006; 17 Sagalowicz (C7RA12008G-(cit6)/*[position()=1]) 2006; 11 Mohammady (C7RA12008G-(cit11)/*[position()=1]) 2009; 96 Kruijff (C7RA12008G-(cit49)/*[position()=1]) 1997; 386 Gerweck (C7RA12008G-(cit41)/*[position()=1]) 1996; 56 Angelova (C7RA12008G-(cit5)/*[position()=1]) 2011; 44 Laughlin (C7RA12008G-(cit18)/*[position()=1]) 1995; 117 Boyd (C7RA12008G-(cit35)/*[position()=1]) 2006; 309 Angelov (C7RA12008G-(cit86)/*[position()=1]) 2007; 129 Shah (C7RA12008G-(cit4)/*[position()=1]) 2001; 47 Collings (C7RA12008G-(cit45)/*[position()=1]) 1997; 66 Vallooran (C7RA12008G-(cit34)/*[position()=1]) 2013; 29 Larsson (C7RA12008G-(cit16)/*[position()=1]) 1989; 93 Barauskas (C7RA12008G-(cit13)/*[position()=1]) 2005; 5 Phan (C7RA12008G-(cit22)/*[position()=1]) 2011; 421 Jiang (C7RA12008G-(cit90)/*[position()=1]) 2017; 72 Asokan (C7RA12008G-(cit40)/*[position()=1]) 2002; 91 Lee (C7RA12008G-(cit58)/*[position()=1]) 2007; 99 Freag (C7RA12008G-(cit114)/*[position()=1]) 2016; 11 Seddon (C7RA12008G-(cit55)/*[position()=1]) 1990; 29 And (C7RA12008G-(cit73)/*[position()=1]) 1996; 12 Amar-Yuli (C7RA12008G-(cit39)/*[position()=1]) 2005; 43 Rosenbaum (C7RA12008G-(cit105)/*[position()=1]) 2010; 388 Cohenavrahami (C7RA12008G-(cit99)/*[position()=1]) 2010; 77 Pouzot (C7RA12008G-(cit21)/*[position()=1]) 2007; 23 Qiu (C7RA12008G-(cit62)/*[position()=1]) 2000; 21 Engström (C7RA12008G-(cit94)/*[position()=1]) 1992; 79 |
| References_xml | – volume: 364 start-page: 2635 issue: 1847 year: 2006 ident: C7RA12008G-(cit100)/*[position()=1] publication-title: Philos. Trans. R. Soc., A doi: 10.1098/rsta.2006.1844 contributor: fullname: Seddon – volume: 23 start-page: 9618 issue: 19 year: 2007 ident: C7RA12008G-(cit21)/*[position()=1] publication-title: Langmuir doi: 10.1021/la701206a contributor: fullname: Pouzot – volume: 66 start-page: 551 issue: 6 year: 1997 ident: C7RA12008G-(cit45)/*[position()=1] publication-title: Am. J. Phys. doi: 10.1119/1.18901 contributor: fullname: Collings – volume: 6 start-page: 723 issue: 5 year: 1996 ident: C7RA12008G-(cit51)/*[position()=1] publication-title: J. Phys. B: At., Mol. Opt. Phys. contributor: fullname: Briggs – volume: 1 start-page: 962 issue: 6 year: 2010 ident: C7RA12008G-(cit29)/*[position()=1] publication-title: J. Phys. Chem. Lett. doi: 10.1021/jz100226v contributor: fullname: Yaghmur – volume: 45 start-page: 448 issue: 3 year: 2002 ident: C7RA12008G-(cit20)/*[position()=1] publication-title: Diabetologia doi: 10.1007/s00125-001-0751-z contributor: fullname: Chung – volume: 75 start-page: 853 issue: 2 year: 1998 ident: C7RA12008G-(cit72)/*[position()=1] publication-title: Biophys. J. doi: 10.1016/S0006-3495(98)77574-5 contributor: fullname: Tenchov – volume: 228 start-page: 67 year: 2016 ident: C7RA12008G-(cit30)/*[position()=1] publication-title: J. Controlled Release doi: 10.1016/j.jconrel.2016.02.042 contributor: fullname: Fong – volume: 17 start-page: 2084 issue: 7 year: 2001 ident: C7RA12008G-(cit53)/*[position()=1] publication-title: Langmuir doi: 10.1021/la0013805 contributor: fullname: Schwarz – volume: 21 start-page: 223 issue: 3 year: 2000 ident: C7RA12008G-(cit62)/*[position()=1] publication-title: Biomaterials doi: 10.1016/S0142-9612(99)00126-X contributor: fullname: Qiu – volume: 1285 start-page: 109 issue: 1 year: 1996 ident: C7RA12008G-(cit71)/*[position()=1] publication-title: Biochim. Biophys. Acta doi: 10.1016/S0005-2736(96)00156-3 contributor: fullname: Tenchov – volume: 78 start-page: 185 issue: 2 year: 2010 ident: C7RA12008G-(cit98)/*[position()=1] publication-title: Colloids Surf., B doi: 10.1016/j.colsurfb.2010.02.029 contributor: fullname: Yariv – volume: 9 start-page: 3602 issue: 21 year: 2013 ident: C7RA12008G-(cit26)/*[position()=1] publication-title: Small doi: 10.1002/smll.201300348 contributor: fullname: Zabara – volume: 3 start-page: 20673 issue: 43 year: 2013 ident: C7RA12008G-(cit67)/*[position()=1] publication-title: RSC Adv. doi: 10.1039/C3RA42737D contributor: fullname: Bertelsen – volume: 129 start-page: 13474 issue: 44 year: 2007 ident: C7RA12008G-(cit86)/*[position()=1] publication-title: J. Am. Chem. Soc. doi: 10.1021/ja072725+ contributor: fullname: Angelov – volume: 28 start-page: 14450 issue: 40 year: 2012 ident: C7RA12008G-(cit28)/*[position()=1] publication-title: Langmuir doi: 10.1021/la302901q contributor: fullname: Fong – volume: 6 start-page: 3017 issue: 9–10 year: 2006 ident: C7RA12008G-(cit111)/*[position()=1] publication-title: J. Nanosci. Nanotechnol. doi: 10.1166/jnn.2006.402 contributor: fullname: Johnsson – volume: 386 start-page: 129 year: 1997 ident: C7RA12008G-(cit49)/*[position()=1] publication-title: Nature doi: 10.1038/386129a0 contributor: fullname: Kruijff – volume: 1031 start-page: 1 issue: 1 year: 1990 ident: C7RA12008G-(cit52)/*[position()=1] publication-title: Biochim. Biophys. Acta doi: 10.1016/0304-4157(90)90002-T contributor: fullname: Seddon – volume: 25 start-page: 13106 issue: 22 year: 2009 ident: C7RA12008G-(cit83)/*[position()=1] publication-title: Langmuir doi: 10.1021/la901195t contributor: fullname: Bitancherbakovsky – volume: 4 start-page: 729 issue: 10 year: 2005 ident: C7RA12008G-(cit77)/*[position()=1] publication-title: Nat. Mater. doi: 10.1038/nmat1496 contributor: fullname: Mezzenga – volume: 22 start-page: 9919 issue: 24 year: 2006 ident: C7RA12008G-(cit88)/*[position()=1] publication-title: Langmuir doi: 10.1021/la061303v contributor: fullname: Yaghmur – volume: 21 start-page: 3322 issue: 8 year: 2005 ident: C7RA12008G-(cit54)/*[position()=1] publication-title: Langmuir doi: 10.1021/la046964b contributor: fullname: Mezzenga – volume: 145 start-page: 084903 issue: 8 year: 2016 ident: C7RA12008G-(cit107)/*[position()=1] publication-title: J. Chem. Phys. doi: 10.1063/1.4961224 contributor: fullname: Antognini – volume: 91 start-page: 1 year: 1994 ident: C7RA12008G-(cit59)/*[position()=1] publication-title: Colloids Surf., A doi: 10.1016/0927-7757(94)02743-9 contributor: fullname: Israelachvili – volume: 17 start-page: 204 issue: 5 year: 2006 ident: C7RA12008G-(cit10)/*[position()=1] publication-title: Trends Food Sci. Technol. doi: 10.1016/j.tifs.2005.12.012 contributor: fullname: Sagalowicz – volume: 14 start-page: 16 issue: 1 year: 2009 ident: C7RA12008G-(cit47)/*[position()=1] publication-title: Curr. Opin. Colloid Interface Sci. doi: 10.1016/j.cocis.2008.01.006 contributor: fullname: Larsson – volume: 28 start-page: 16455 issue: 47 year: 2012 ident: C7RA12008G-(cit87)/*[position()=1] publication-title: Langmuir doi: 10.1021/la303833s contributor: fullname: Negrini – volume: 11 start-page: 4799 year: 2016 ident: C7RA12008G-(cit114)/*[position()=1] publication-title: Int. J. Nanomed. doi: 10.2147/IJN.S111736 contributor: fullname: Freag – volume: 29 start-page: 7997 issue: 34 year: 1990 ident: C7RA12008G-(cit55)/*[position()=1] publication-title: Biochemistry doi: 10.1021/bi00486a031 contributor: fullname: Seddon – volume: 21 start-page: 3298 year: 2015 ident: C7RA12008G-(cit63)/*[position()=1] publication-title: Med. Sci. Monit. doi: 10.12659/MSM.894484 contributor: fullname: Li – volume: 11 start-page: 11687 issue: 11 year: 2017 ident: C7RA12008G-(cit43)/*[position()=1] publication-title: ACS Nano doi: 10.1021/acsnano.7b06838 contributor: fullname: Speziale – volume: 2 start-page: 2039 issue: 11 year: 1992 ident: C7RA12008G-(cit50)/*[position()=1] publication-title: J. Phys. B: At., Mol. Opt. Phys. contributor: fullname: Turner – volume: 70 start-page: 765 issue: 3 year: 2008 ident: C7RA12008G-(cit106)/*[position()=1] publication-title: Eur. J. Pharm. Biopharm. doi: 10.1016/j.ejpb.2008.07.008 contributor: fullname: Ahmed – volume: 37 start-page: 56 issue: 1 year: 2011 ident: C7RA12008G-(cit24)/*[position()=1] publication-title: Drug Dev. Ind. Pharm. doi: 10.3109/03639045.2010.491830 contributor: fullname: Kwon – volume: 29 start-page: 999 issue: 4 year: 2013 ident: C7RA12008G-(cit34)/*[position()=1] publication-title: Langmuir doi: 10.1021/la304563r contributor: fullname: Vallooran – volume: 5 start-page: 1615 issue: 8 year: 2005 ident: C7RA12008G-(cit13)/*[position()=1] publication-title: Nano Lett. doi: 10.1021/nl050678i contributor: fullname: Barauskas – volume: 309 start-page: 218 issue: 1–2 year: 2006 ident: C7RA12008G-(cit35)/*[position()=1] publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2005.11.033 contributor: fullname: Boyd – volume: 30 start-page: 14452 issue: 48 year: 2014 ident: C7RA12008G-(cit64)/*[position()=1] publication-title: Langmuir doi: 10.1021/la5038662 contributor: fullname: Martiel – volume: 1 start-page: 653 year: 1996 ident: C7RA12008G-(cit44)/*[position()=1] publication-title: Curr. Opin. Solid State Mater. Sci. doi: 10.1016/S1359-0286(96)80047-7 contributor: fullname: Hyde – volume: 112 start-page: 3971 issue: 13 year: 2008 ident: C7RA12008G-(cit91)/*[position()=1] publication-title: J. Phys. Chem. B doi: 10.1021/jp711421k contributor: fullname: Yuli – volume: 26 start-page: 3648 issue: 5 year: 2010 ident: C7RA12008G-(cit82)/*[position()=1] publication-title: Langmuir doi: 10.1021/la903100m contributor: fullname: Bitancherbakovsky – volume: 22 start-page: 517 issue: 2 year: 2006 ident: C7RA12008G-(cit84)/*[position()=1] publication-title: Langmuir doi: 10.1021/la052109w contributor: fullname: Yaghmur – volume: 340 start-page: 52 issue: 1–2 year: 2007 ident: C7RA12008G-(cit95)/*[position()=1] publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2007.03.020 contributor: fullname: Boyd – volume: 8 start-page: 4957 issue: 43 year: 2006 ident: C7RA12008G-(cit3)/*[position()=1] publication-title: Phys. Chem. Chem. Phys. doi: 10.1039/b609510k contributor: fullname: Kaasgaard – volume: 43 start-page: 72 issue: 2 year: 2005 ident: C7RA12008G-(cit39)/*[position()=1] publication-title: Colloids Surf., B doi: 10.1016/j.colsurfb.2005.03.011 contributor: fullname: Amar-Yuli – volume: 32 start-page: 209 issue: 3 year: 2007 ident: C7RA12008G-(cit96)/*[position()=1] publication-title: Eur. J. Pharm. Sci. doi: 10.1016/j.ejps.2007.07.006 contributor: fullname: Lopes – volume: 129 start-page: 163 issue: 3 year: 2008 ident: C7RA12008G-(cit92)/*[position()=1] publication-title: J. Controlled Release doi: 10.1016/j.jconrel.2008.04.020 contributor: fullname: Bender – volume: 46 start-page: 2 issue: 1 year: 1996 ident: C7RA12008G-(cit104)/*[position()=1] publication-title: Rev. Port. Farm. contributor: fullname: Costa – volume: 3 start-page: 700 issue: 7 year: 2012 ident: C7RA12008G-(cit46)/*[position()=1] publication-title: Food Funct. doi: 10.1039/c2fo00005a contributor: fullname: Garti – volume: 135 start-page: 218 issue: 3 year: 2009 ident: C7RA12008G-(cit19)/*[position()=1] publication-title: J. Controlled Release doi: 10.1016/j.jconrel.2009.01.009 contributor: fullname: Fong – volume: 7 start-page: 1 issue: 1–4 year: 2012 ident: C7RA12008G-(cit32)/*[position()=1] publication-title: Biointerphases contributor: fullname: Fong – volume: 41 start-page: 692 issue: 5 year: 2010 ident: C7RA12008G-(cit61)/*[position()=1] publication-title: Eur. J. Pharm. Sci. doi: 10.1016/j.ejps.2010.09.012 contributor: fullname: Han – volume: 72 start-page: 249 issue: 5 year: 2017 ident: C7RA12008G-(cit90)/*[position()=1] publication-title: J. Pharm. Sci. contributor: fullname: Jiang – volume: 204 start-page: 78 year: 2015 ident: C7RA12008G-(cit65)/*[position()=1] publication-title: J. Controlled Release doi: 10.1016/j.jconrel.2015.02.034 contributor: fullname: Martiel – volume: 13 start-page: 123 issue: 2 year: 2001 ident: C7RA12008G-(cit103)/*[position()=1] publication-title: Eur. J. Pharm. Sci. doi: 10.1016/S0928-0987(01)00095-1 contributor: fullname: Costa – volume: 340 start-page: 52 issue: 1–2 year: 2007 ident: C7RA12008G-(cit66)/*[position()=1] publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2007.03.020 contributor: fullname: Boyd – volume: 46 start-page: 215 issue: 3 year: 1997 ident: C7RA12008G-(cit23)/*[position()=1] publication-title: J. Controlled Release doi: 10.1016/S0168-3659(96)01596-9 contributor: fullname: Chang – volume: 26 start-page: 6136 issue: 26 year: 2010 ident: C7RA12008G-(cit27)/*[position()=1] publication-title: Langmuir doi: 10.1021/la100644s contributor: fullname: Fong – volume: 117 start-page: 10203 issue: 35 year: 2013 ident: C7RA12008G-(cit31)/*[position()=1] publication-title: J. Phys. Chem. B doi: 10.1021/jp403840m contributor: fullname: Tangso – volume: 391 start-page: 284 issue: 1–2 year: 2010 ident: C7RA12008G-(cit117)/*[position()=1] publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2010.03.016 contributor: fullname: Barauskas – volume: 4 start-page: 449 issue: 6 year: 1999 ident: C7RA12008G-(cit9)/*[position()=1] publication-title: Curr. Opin. Colloid Interface Sci. doi: 10.1016/S1359-0294(00)00020-0 contributor: fullname: Drummond – volume: 315 start-page: 701 issue: 2 year: 2007 ident: C7RA12008G-(cit36)/*[position()=1] publication-title: J. Colloid Interface Sci. doi: 10.1016/j.jcis.2007.07.011 contributor: fullname: Wadsten-Hindrichsen – volume: 16 start-page: 846 issue: 4 year: 2015 ident: C7RA12008G-(cit89)/*[position()=1] publication-title: AAPS PharmSciTech doi: 10.1208/s12249-014-0277-6 contributor: fullname: Chen – volume: 62 start-page: 844 issue: 7 year: 2010 ident: C7RA12008G-(cit110)/*[position()=1] publication-title: J. Pharm. Pharmacol. doi: 10.1211/jpp.62.07.0005 contributor: fullname: Nguyen – volume: 153 start-page: 180 issue: 2 year: 2011 ident: C7RA12008G-(cit14)/*[position()=1] publication-title: J. Controlled Release doi: 10.1016/j.jconrel.2011.03.033 contributor: fullname: Nguyen – volume: 41 start-page: 1297 issue: 3 year: 2012 ident: C7RA12008G-(cit60)/*[position()=1] publication-title: Chem. Soc. Rev. doi: 10.1039/C1CS15148G contributor: fullname: Fong – volume: 23 start-page: 3932 issue: 34 year: 2011 ident: C7RA12008G-(cit33)/*[position()=1] publication-title: Adv. Mater. doi: 10.1002/adma.201101760 contributor: fullname: Vallooran – volume: 117 start-page: 10603 issue: 42 year: 1995 ident: C7RA12008G-(cit18)/*[position()=1] publication-title: J. Am. Chem. Soc. doi: 10.1021/ja00147a600 contributor: fullname: Laughlin – volume: 96 start-page: 1537 issue: 4 year: 2009 ident: C7RA12008G-(cit11)/*[position()=1] publication-title: Biophys. J. doi: 10.1016/j.bpj.2008.10.057 contributor: fullname: Mohammady – volume: 22 start-page: 9512 issue: 23 year: 2006 ident: C7RA12008G-(cit78)/*[position()=1] publication-title: Langmuir doi: 10.1021/la061706v contributor: fullname: Dong – volume: 10 start-page: 383 issue: 5 year: 2002 ident: C7RA12008G-(cit15)/*[position()=1] publication-title: Pigm. Resin Technol. contributor: fullname: Holmberg – volume: 29 start-page: 8222 issue: 26 year: 2013 ident: C7RA12008G-(cit81)/*[position()=1] publication-title: Langmuir doi: 10.1021/la305052q contributor: fullname: Sagalowicz – volume: 67 start-page: 217 issue: 3 year: 2010 ident: C7RA12008G-(cit102)/*[position()=1] publication-title: Acta Pol. Pharm. contributor: fullname: Dash – volume: 308 start-page: 514 issue: 2 year: 2007 ident: C7RA12008G-(cit7)/*[position()=1] publication-title: J. Colloid Interface Sci. doi: 10.1016/j.jcis.2006.12.084 contributor: fullname: Libster – volume: 365 start-page: 190 issue: 1–2 year: 2009 ident: C7RA12008G-(cit108)/*[position()=1] publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2008.08.022 contributor: fullname: Lee – volume: 318 start-page: 154 issue: 1–2 year: 2006 ident: C7RA12008G-(cit109)/*[position()=1] publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2006.03.010 contributor: fullname: Boyd – volume: 29 start-page: 15805 issue: 51 year: 2013 ident: C7RA12008G-(cit57)/*[position()=1] publication-title: Langmuir doi: 10.1021/la404307x contributor: fullname: Martiel – volume: 107 start-page: 97 issue: 1 year: 2005 ident: C7RA12008G-(cit2)/*[position()=1] publication-title: J. Controlled Release doi: 10.1016/j.jconrel.2005.05.015 contributor: fullname: Clogston – volume: 27 start-page: 1073 issue: 10 year: 2001 ident: C7RA12008G-(cit93)/*[position()=1] publication-title: Drug Dev. Ind. Pharm. doi: 10.1081/DDC-100108370 contributor: fullname: Helledi – volume: 64 start-page: 129 issue: 1 year: 1993 ident: C7RA12008G-(cit69)/*[position()=1] publication-title: Biophys. J. doi: 10.1016/S0006-3495(93)81347-X contributor: fullname: Eriksson – volume: 7 start-page: 661 issue: 5 year: 1997 ident: C7RA12008G-(cit8)/*[position()=1] publication-title: Curr. Opin. Struct. Biol. doi: 10.1016/S0959-440X(97)80075-9 contributor: fullname: Luzzati – volume: 52 start-page: 145 issue: 2 year: 1987 ident: C7RA12008G-(cit68)/*[position()=1] publication-title: Biophys. J. doi: 10.1016/S0006-3495(87)83202-2 contributor: fullname: Sjölund – volume: 478 start-page: 569 issue: 2 year: 2015 ident: C7RA12008G-(cit76)/*[position()=1] publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2014.11.072 contributor: fullname: Milak – volume: 44 start-page: 147 issue: 2 year: 2011 ident: C7RA12008G-(cit5)/*[position()=1] publication-title: Acc. Chem. Res. doi: 10.1021/ar100120v contributor: fullname: Angelova – volume: 67 start-page: 166 issue: 1 year: 2007 ident: C7RA12008G-(cit38)/*[position()=1] publication-title: Eur. J. Pharm. Biopharm. doi: 10.1016/j.ejpb.2007.01.001 contributor: fullname: Shah – volume: 12 start-page: 207 issue: 2 year: 1962 ident: C7RA12008G-(cit48)/*[position()=1] publication-title: J. Cell Biol. doi: 10.1083/jcb.12.2.207 contributor: fullname: Luzzati – volume: 388 start-page: 52 issue: 1 year: 2010 ident: C7RA12008G-(cit105)/*[position()=1] publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2009.12.032 contributor: fullname: Rosenbaum – volume: 129 start-page: 198 year: 2015 ident: C7RA12008G-(cit112)/*[position()=1] publication-title: Colloids Surf., B doi: 10.1016/j.colsurfb.2015.03.051 contributor: fullname: Parmar – volume: 35 start-page: 34 issue: 5 year: 1982 ident: C7RA12008G-(cit12)/*[position()=1] publication-title: Phys. Today doi: 10.1063/1.2915092 contributor: fullname: Pershan – volume: 5 start-page: 1615 issue: 8 year: 2005 ident: C7RA12008G-(cit116)/*[position()=1] publication-title: Nano Lett. doi: 10.1021/nl050678i contributor: fullname: Barauskas – volume: 731 start-page: 177 issue: 2 year: 1983 ident: C7RA12008G-(cit70)/*[position()=1] publication-title: Biochim. Biophys. Acta doi: 10.1016/0005-2736(83)90007-X contributor: fullname: Boni – volume: 514 start-page: 314 issue: 1 year: 2016 ident: C7RA12008G-(cit80)/*[position()=1] publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2016.06.138 contributor: fullname: Báez-Santos – volume: 448 start-page: 87 issue: 1 year: 2013 ident: C7RA12008G-(cit113)/*[position()=1] publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2013.03.016 contributor: fullname: Bode – volume: 22 start-page: 2163 issue: 12 year: 2005 ident: C7RA12008G-(cit97)/*[position()=1] publication-title: Pharm. Res. doi: 10.1007/s11095-005-8176-x contributor: fullname: Esposito – volume: 47 start-page: 229 issue: 2 year: 2001 ident: C7RA12008G-(cit4)/*[position()=1] publication-title: Adv. Drug Delivery Rev. doi: 10.1016/S0169-409X(01)00108-9 contributor: fullname: Shah – volume: 79 start-page: 113 issue: 2–3 year: 1992 ident: C7RA12008G-(cit94)/*[position()=1] publication-title: Int. J. Pharm. doi: 10.1016/0378-5173(92)90102-8 contributor: fullname: Engström – volume: 19 start-page: 9562 issue: 23 year: 2003 ident: C7RA12008G-(cit37)/*[position()=1] publication-title: Langmuir doi: 10.1021/la0350812 contributor: fullname: Barauskas – volume: 454 start-page: 625 issue: 2 year: 2013 ident: C7RA12008G-(cit115)/*[position()=1] publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2013.06.006 contributor: fullname: Angelova – volume: 421 start-page: 176 issue: 1 year: 2011 ident: C7RA12008G-(cit22)/*[position()=1] publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2011.09.022 contributor: fullname: Phan – volume: 99 start-page: 187801 issue: 18 year: 2007 ident: C7RA12008G-(cit58)/*[position()=1] publication-title: Phys. Rev. Lett. doi: 10.1103/PhysRevLett.99.187801 contributor: fullname: Lee – volume: 26 start-page: 1177 issue: 2 year: 2010 ident: C7RA12008G-(cit101)/*[position()=1] publication-title: Langmuir doi: 10.1021/la9023019 contributor: fullname: Yaghmur – volume: 77 start-page: 131 issue: 2 year: 2010 ident: C7RA12008G-(cit99)/*[position()=1] publication-title: Colloids Surf., B doi: 10.1016/j.colsurfb.2010.01.013 contributor: fullname: Cohenavrahami – volume: 7 start-page: 20438 issue: 36 year: 2015 ident: C7RA12008G-(cit79)/*[position()=1] publication-title: ACS Appl. Mater. Interfaces doi: 10.1021/acsami.5b06413 contributor: fullname: Kim – volume: 27 start-page: 5296 issue: 9 year: 2011 ident: C7RA12008G-(cit25)/*[position()=1] publication-title: Langmuir doi: 10.1021/la200591u contributor: fullname: Negrini – volume: 17 start-page: 7742 issue: 25 year: 2001 ident: C7RA12008G-(cit85)/*[position()=1] publication-title: Langmuir doi: 10.1021/la010650w contributor: fullname: Borné – volume: 111 start-page: 1384 issue: 6 year: 2007 ident: C7RA12008G-(cit74)/*[position()=1] publication-title: J. Phys. Chem. B doi: 10.1021/jp0659655 contributor: fullname: Fong – volume: 5 start-page: 64 issue: 1 year: 2000 ident: C7RA12008G-(cit17)/*[position()=1] publication-title: Curr. Opin. Colloid Interface Sci. doi: 10.1016/S1359-0294(00)00040-6 contributor: fullname: Larsson – volume: 12 start-page: 1658 issue: 6 year: 1996 ident: C7RA12008G-(cit73)/*[position()=1] publication-title: Langmuir doi: 10.1021/la950326z contributor: fullname: And – volume: 91 start-page: 903 issue: 4 year: 2002 ident: C7RA12008G-(cit40)/*[position()=1] publication-title: J. Pharm. Sci. doi: 10.1002/jps.10095 contributor: fullname: Asokan – volume: 46 start-page: 1923 issue: 9 year: 2010 ident: C7RA12008G-(cit75)/*[position()=1] publication-title: Eur. Polym. J. doi: 10.1016/j.eurpolymj.2010.07.001 contributor: fullname: Didehban – volume: 11 start-page: 224 issue: 4 year: 2006 ident: C7RA12008G-(cit6)/*[position()=1] publication-title: Curr. Opin. Colloid Interface Sci. doi: 10.1016/j.cocis.2006.07.002 contributor: fullname: Sagalowicz – volume: 113 start-page: 7491 issue: 27 year: 2016 ident: C7RA12008G-(cit42)/*[position()=1] publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.1603965113 contributor: fullname: Speziale – volume: 2 start-page: 4485 issue: 2 year: 2000 ident: C7RA12008G-(cit56)/*[position()=1] publication-title: Phys. Chem. Chem. Phys. doi: 10.1039/b004916f contributor: fullname: Seddon – volume: 56 start-page: 1194 issue: 6 year: 1996 ident: C7RA12008G-(cit41)/*[position()=1] publication-title: Cancer Res. contributor: fullname: Gerweck – volume: 7 start-page: 1133 issue: 10 year: 2010 ident: C7RA12008G-(cit1)/*[position()=1] publication-title: Expert Opin. Drug Delivery doi: 10.1517/17425247.2010.515584 contributor: fullname: Rizwan – volume: 93 start-page: 512 issue: 21 year: 1989 ident: C7RA12008G-(cit16)/*[position()=1] publication-title: J. Phys. Chem. doi: 10.1021/j100358a010 contributor: fullname: Larsson |
| SSID | ssj0000651261 |
| Score | 2.5613217 |
| SecondaryResourceType | review_article |
| Snippet | Lyotropic liquid crystals (LLCs) formed by the self-assembly of amphiphilic molecules in a solvent (usually water) have attracted increasingly greater... |
| SourceID | pubmedcentral proquest crossref pubmed rsc |
| SourceType | Open Access Repository Aggregation Database Index Database Publisher |
| StartPage | 6978 |
| SubjectTerms | Active control Additives Chemistry Diffusion Hexagonal phase Liquid crystals Moisture content Molecular structure Phase transitions Self-assembly |
| Title | Factors affecting the structure of lyotropic liquid crystals and the correlation between structure and drug diffusion |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/35540315 https://www.proquest.com/docview/2010887958 https://search.proquest.com/docview/2662547682 https://pubmed.ncbi.nlm.nih.gov/PMC9078419 |
| Volume | 8 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6xPUAvqBQKgVIZwTXdzcOOc6y2XXopQjwkbpE9tkukbbKkzaH_nrGTLF31xiEnj53EM8k8PR_Ap1RYmUknYyN8tEqTz6rIj4i5tS5FzZ1e-IPCl9-LL7_k-YVvk8OnszChaB91fdqsb06b-neordzc4HyqE5t_vVqSQyfzpJzPYEa24QMXffj9kg4TydSKNCvnWHQq8Xn-63146vWrRzbY1UOPjMvHNZKzboIECapndQDPR5uRnQ3P9gKe2OYQni0nqLaX0K8G1BymQnUGaSNGdh0besP2nWWtY-v79q5rNzWydf2nrw3D7p4swzVNakwgRw_UMZTGsbF868ESnsp0_TXzkCq9j7G9gp-rix_Ly3jEU4iRZ_wuRrEo6dLGJcZwlAvEtMRM5UKmhbTWaqfL3HJMdOJIuy1SJTKdckdTlMtFdgR7TdvYN8B0YQx6HHXuTI65Jf4mmRKlkqilKosIPk67W22GthlVSHdnZbUsvp0FdnyO4Hja-Gr8dG4rn56XHgJdRvBhO0wb6jMZqrFtTzSC3LacPKU0gtcDn7a3mRgcQbHDwS2Bb6i9O0JyFhprj3IVwRHxekv_T3ze_veS72Cf3ksOsZtj2CPm2fcwuzX9SYgCnAQZ_gsKnvrd |
| link.rule.ids | 230,315,729,782,786,866,887,27934,27935,53802,53804 |
| linkProvider | National Library of Medicine |
| linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6xRaK9lGchUMAIrunmZcc5VkuXRbQVgiJxi_xsI22Tbdoc-u8ZO8nSVW895OSx8_jGGY9nPB_Al4QZnnLLQ83cbpVEn1WgHxFSY2yiJLUycgeFF7_z07_865Erk0PHszA-aV_J6qBeXh7U1YXPrVxdqumYJzb9eTJDh45ncTGdwGOcr1Fyx0nvf8BoxVg8FiNNi6nKWxG7SP_5DjxxFtZxG2xaonvLy_tZkpN2JAXxxmf-9IGP_Qx2h9UmOeybn8MjU7-A7dlI8vYSunnPt0OEz-tAO0ZwRUj6qrJda0hjyfK2uWmbVaXIsrrqKk1Ue4tryiV2qrUXV47io0-qI0Pi150hnJRuu3PiyFg6tzv3Cv7Mj85mi3BgYggVTelNqFhU4CW1jbWmikdKJYVKRcZ4knNjjLSyyAxVsYwt2sUoESyVCbXYRdiMpXuwVTe1eQNE5lorx8BOrc5UZlAz4lSwQnAluSjyAD6PqJSrvuBG6QPlaVHO8l-HHsZvAeyPgJXDpLsuXWCfO_J0HsCndTN-UBcDEbVpOpRh6PBl6GMlAbzu8V3fZlSMAPIN5NcCrhT3ZgtC7UtyD9AGsIc6spb_r3ZvHzzkR9henJ0cl8ffT3-8gx18R97vAO3DFgJp3sPkWncf_Az4B1eZD4c |
| linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1JT90wEB71UYlygW60aaF11V5Ddsc5ogevVG0R6iL1FnmlkR7JayAH_j1jZ4EnbuWQU8bO8o0zM57JfACfYqpZwgzzFbW7VQJjVo5xhJ9pbWIpMiNC-6Pwyc_89A87OrZtciaqL1e0L0V1UC8vDurqr6utXF3IYKwTC86-zzGgY2lUBCtlghk8xjUbpncC9f4jjJaMRmND0qQIZN7yyGb7z7dg01pZy2-wbo3uuZj3KyVn7UgM4gzQYucBt_4Utgevkxz2Is_gka6fw5P5SPb2ArpFz7tDuKvvQHtG0DMkfXfZrtWkMWR53Vy1zaqSZFn96ypFZHuNvuUSB9XKiUtL9dEX15GhAOzOFFZKtd05saQsnd2lewm_F8e_5if-wMjgyyzJrnxJwwIPoUykVCZZKGVcyISnlMU501oLI4pUZzISkUH7GMacJiLODA7hJqXJLmzUTa1fAxG5UtIysWdGpTLVqCFRwmnBmRSMF7kHH0dkylXfeKN0CfOkKOf5j0MH5WcP9kbQymHxXZY2wc8siTrz4MN0Gl-ozYXwWjcdylAM_FKMtWIPXvUYT5cZlcODfA39ScC25F4_g3C71twDvB7sop5M8req9-a_p3wPm2dHi_Lbl9Ovb2ELH5H1G0F7sIE46n2YXarunVsEN76sEgc |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Factors+affecting+the+structure+of+lyotropic+liquid+crystals+and+the+correlation+between+structure+and+drug+diffusion&rft.jtitle=RSC+advances&rft.au=Huang%2C+Yiming&rft.au=Gui%2C+Shuangying&rft.date=2018-01-01&rft.eissn=2046-2069&rft.volume=8&rft.issue=13&rft.spage=6978&rft.epage=6987&rft_id=info:doi/10.1039%2Fc7ra12008g&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2046-2069&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2046-2069&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2046-2069&client=summon |